Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.
Abhinav SharmaAmir RazaghizadAbdulaziz JouryAdeera LevinHarpreet S BajajG B John ManciniNorman C WongApril E HebertFernando G AngWally RapattoniBrendon L NeuenClare ArnottVlado PerkovicKenneth W MahaffeyPublished in: Journal of the American Heart Association (2024)
URL: https://www.clinicaltrials.gov; Unique identifiers: NCT01032629, NCT01989754, NCT02065791.